CPA
INSM icon

Capital Performance Advisors’s Insmed INSM Stock Holding History

Capital Performance Advisors’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-23
Closed -$1.68K – 1363
2024
Q3 		$1.68K Buy
+23
New +$1.7K ﹤0.01% 1653

Other funds holding INSM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Performance Advisors's INSM Position: Q4 2024 in Review

Capital Performance Advisors sold out of Insmed (INSM) in Q4 2024, closing a stake of 23 shares — an estimated $1.68K sold.

Capital Performance Advisors first reported a position in INSM in Q3 2024 and held it in 1 quarter. The position peaked at $1.68K in Q3 2024. 438 funds tracked by Wall St. Rank hold INSM as of Q4 2024.

  • Capital Performance Advisors reported no remaining Insmed position as of Q4 2024 after selling out during the quarter.
  • Capital Performance Advisors sold 23 Insmed shares in Q4 2024, an estimated $1.68K.
  • Capital Performance Advisors first reported a position in Insmed in Q3 2024 and held it in 1 quarter.
  • Capital Performance Advisors's Insmed position peaked at $1.68K in Q3 2024.
  • 438 funds tracked by Wall St. Rank held Insmed as of Q4 2024.

Based on Capital Performance Advisors's 13F filing for Q4 2024, filed 31 Jan 2025.